$TER

JOHNSON MERCEDES sold $59K of TER

JOHNSON MERCEDES sold 166 shares of TERADYNE, INC (TER) at $358.15 on 2026-08-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · JOHNSON MERCEDES
Published Aug 4, 2026, 3:10 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 3:28 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$TER
Neutral
high confidence
Mentioned
$TER
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TERNeutralLow
01

Why it matters

The disclosed event is an open-market sale by a director under a Rule 10b5-1 plan, which generally reduces the informational content versus discretionary selling.

02

Market read

Traders may note the sale for sentiment, but there is no new company-specific fundamental information in the text.

03

What to watch

The article does not state whether this sale is part of a larger multi-tranche program size or whether other insiders filed around the same time, which would matter for interpreting signal strength.

Relevance 2/10Novelty 3/10Timing: filed 2026-08-04, transaction dated 2026-08-03

Background

The article is an SEC Form 4 insider transaction disclosure for Teradyne, Inc.

Company-level read

Ticker impact

$TERNeutralHigh confidence
Context

Teradyne Form 4 shows director Johnson Mercedes sold 166 shares at $358.15 on 2026-08-03 under a 10b5-1 plan.

Expected impact

Likely negligible to modest, mostly sentiment-only, unless follow-on filings show unusual selling patterns.

Evidence & confidence

The filing is an open-market sale by a director, explicitly under a Rule 10b5-1 plan, and the article provides no new operational, financial, or regulatory catalyst.

Market effects

No direct sector read-through; insider sales under 10b5-1 are typically not informative for the broader industrial/automation space.

None indicated.

None indicated.

Counterpoint

A cluster of director 10b5-1 sales over a short window can still coincide with internal views on valuation or risk, even if the plan is pre-arranged.

Key entities

  • TERADYNE, INC

    US-listed company whose Form 4 insider transaction is disclosed.

  • JOHNSON MERCEDES

    Director who sold 166 shares at $358.15 under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$FORMMedAI 8/10

FormFactor, Entegris, Penguin Solutions, Teradyne, and Marvell Technology Stocks Trade Up, What You Need To Know

Several semiconductor stocks rose after the August jobs report, which showed 162,000 nonfarm payroll jobs added, beating estimates. Despite initial expectations of a rate hike, traders rotated back into the chip sector. FormFactor (FORM) +5.3%, Entegris (ENTG) +5.6%, Penguin Solutions (PENG) +5.1%, Teradyne (TER) +4.8%, and Marvell Technology (MRVL) +6.2%. Marvell reported Q2 revenue of $2.74B, up 36.5% YoY, with strong Data Center demand. Management guided Q3 revenue at $3.15B, but revenue from

$TERMed

Teradyne Stock Plunges 15% in a Month: Should You Buy the Dip?

Teradyne (TER) shares fell 15.4% in a month, underperforming peers and sector. Challenges include customer concentration and muted demand, but AI-driven data center growth and strong Q3 guidance offset this. TER expects $1.20-$1.30B revenue and $1.85-$2.15 EPS for Q3 2026, up significantly YoY. The stock trades at a premium with a forward P/S of 9.35X.

$TERHigh

Why is Teradyne stock sliding today?

Teradyne (TER) stock fell 3.9% after Baird downgraded it to Neutral with a $420 price target, citing stretched valuation and concerns over AI and hyperscaler spending sustainability. The firm argues GPU testing catalyst is priced in and next growth drivers are too distant. TER's decline contrasts with broader market gains, highlighting company-specific pressures.

$METAMed

Stocks making the biggest moves midday: Meta, Amylyx, Baidu, Klarna, Coherent, Sandisk & more

Amylyx Pharmaceuticals shares rose 53% after its avexitide treatment met trial endpoints. Meta Platforms fell 3% amid a lawsuit. Carvana dropped 3% after director stock sales. UGI Corporation surged 12% on a $9B KKR bid report. AI-related stocks declined. Klarna fell 21% on weak guidance. Baidu dropped 12% on earnings miss. Home Depot rose slightly on earnings beat. Fabrinet fell 20% on margin concerns. Memory stocks declined. Duolingo rose 7% on an upgrade.